MSB 3.33% $1.40 mesoblast limited

If MSB is to be removed from S&P ASX 200...., page-202

  1. 1,972 Posts.
    lightbulb Created with Sketch. 859
    The focus of Mesoblast is on its Phase 3 product candidates for congestive heart failure, chronic back pain due to disc degeneration and biologic refractory acute graft verses host disease. Aren't these not multiple shots at goal.
    This strategy is sound business practice.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.